Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma

NCT00183989 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Insufficient accrual

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: Fludarabine, Mitoxantrone and Rituximab

Sponsor

University of Southern California